sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseFood & Beverages

Reduced Starch Syrup Market to Reach USD 5.56 billion by 2034 at 7.32% CAGR

Low-Saccharified Syrup is the fastest-growing line at 7.81%; Asia Pacific is the largest region at 41.69% of 2025 revenue.

PUNE, INDIA — 21 AUGUST 2026 — CONTRIVE DATUM INSIGHTS

From USD 2.95 billion in 2025 to USD 5.56 billion in 2034, a 7.32% compound annual rate.

41.69% of 2025 revenue (USD 1.23 billion) is generated in Asia Pacific.

Low-Saccharified Syrup is the fastest-growing line at 7.81% annually.

45.08% of 2025 revenue sits in Low-Saccharified Syrup, the largest type line.

Reformulation toward reduced-sugar and clean-label food products is pulling the reduced starch syrup market forward, and the study rates its impact on growth as high. Food makers want less sweetness and a lighter sugar load without giving up texture, moisture retention or shelf stability. Reduced starch syrup does that work. It is made by partial enzymatic or acid hydrolysis of corn, potato, cassava or wheat starch, formulated to a lower sweetness and dextrose equivalent than standard glucose syrup, and sold as an ingredient in liquid or dried powder form. Confectionery, bakery, dairy, frozen dessert and jam producers are the main buyers, with pharmaceutical and nutraceutical formulators taking a smaller share.

Contrive Datum Insights values the global reduced starch syrup market at USD 2.95 billion in 2025. It is projected to reach USD 3.16 billion in 2026 and USD 5.56 billion by 2034, a compound annual growth rate of 7.32% over the forecast period. The figures come from the report "Reduced Starch Syrup Market Size, Share & Industry Analysis", which covers type, application, source, form and end-use industry, with a regional forecast for 2026 to 2034.

Low-Saccharified Syrup benefits most from the shift. It grows at 7.81%, the fastest of any type line, and its share of revenue moves from 45.08% in 2025 to 46.94% in 2034 as its value climbs from USD 1.33 billion to USD 2.61 billion. Confectionery Syrup holds 34.92% of 2025 revenue and grows at 6.57%, so it trails the market. Other axes show the same pull toward newer formats. Dairy Products grows fastest by application at 9.08%, Cassava/Tapioca by source at 9.55%, Powder by form at 9.32%, and Pharmaceuticals & Nutraceuticals by end-use industry at 10.92%. The established positions stay large all the same: Confectionery leads applications at 37.97%, Corn leads sources at 54.92%, Liquid leads forms at 77.97%, and Food & Beverage leads end uses at 84.07%.

Demand is concentrated in Asia Pacific, which accounts for 41.69% of 2025 revenue, or USD 1.23 billion. The region reaches USD 2.5 billion by 2034 and raises its share to 44.96%. China is the largest single country market at USD 0.49 billion in 2025, 16.61% of global revenue. Middle East and Africa is the smallest region throughout, at 5.08% in 2025 and 5.04% by 2034.

The study also tests how the forecast could fail. Its bear case assumes feedstock price volatility and slower regulatory approval of reformulated reduced-sugar products hold back adoption, keeping volume growth near the historical trend and 2034 revenue at USD 5.03 billion. Starch is an agricultural input, so a poor harvest year or a delayed approval can slow buyers who are mid-reformulation. The bull case runs the other way. Faster substitution away from sucrose and high-fructose corn syrup in confectionery and dairy, together with quicker capacity expansion at Asia Pacific starch processors, lifts 2034 revenue to USD 6.09 billion.

The report gives revenue and growth for every line in every year from 2020 to 2034 across five segmentation axes. It covers all five regions with country-level breakdowns, the competitive landscape and the research methodology behind each estimate. It is delivered as a PDF, and a free sample is available on request.

Regions Covered
Asia PacificEuropeNorth AmericaLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078